Lactylation at the crossroads of metabolism and epigenetics in neuroinflammation
Frontiers in Immunology · 2026
DOI: 10.3389/fimmu.2026.1784112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Haoyue Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neuroinflammatory Diseases, Protein Processing, Post-Translational, Lactic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lactate has moved from being viewed as an inert glycolytic end-product to a pleiotropic metabolite that shapes cellular signaling and gene regulation. A major inflection point is the identification of lysine lactylation (Kla), a post-translational modification that can couple glycolytic state to chromatin remodeling and protein function. In the central nervous system, lactate production, compartmentalization, and transport—coordinated by cell-type–specific expression of lactate dehydrogenases and monocarboxylate transporters within the neurovascular unit—create dynamic microenvironments that are increasingly recognized as determinants of neuroinflammatory tone. Emerging evidence indicates that Kla occurs on both histone and non-histone substrates and can reprogram inflammatory and stress-response networks in microglia, astrocytes, endothelial cells, and neurons, intersecting with canonical pathways such as NF-κB, inflammasome signaling, and cytokine-driven transcriptional programs. However, the field faces key mechanistic and translational gaps, including incomplete definition of Kla “writers/erasers/readers,” uncertainty about the quantitative relationship between lactate flux and site-specific lactylation, and marked context dependence across disease stage, cell state, and brain region. This review integrates current understanding of CNS lactate metabolism and trafficking with the expanding landscape of Kla biology, synthesizes cell- and disease-specific evidence across acute injury and neurodegeneration, and outlines priorities for causal mapping, biomarker development, and time-windowed, cell-targeted therapeutic strategies that attenuate maladaptive inflammation without compromising repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Lanzhou University Second Hospital, Lanzhou, China.
- Department of Ophthalmology, Lanzhou University Second Hospital, Lanzhou, China.
- Institute of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
- Department of Neurology, Qinghai Provincial People's Hospital, Xining, China.
- The Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Zitieren
APA
Wang, H., Shao, K., Zhou, R., Xi, J., Zhang, W., Hao, Y., Song, J., & Ge, Z. (2026). Lactylation at the crossroads of metabolism and epigenetics in neuroinflammation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1784112
Vancouver
Wang H, Shao K, Zhou R, Xi J, Zhang W, Hao Y, et al. Lactylation at the crossroads of metabolism and epigenetics in neuroinflammation. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1784112
BibTeX
@article{Wang2026,
author = {Wang, Haoyue and Shao, Kangmei and Zhou, Ran and Xi, Jiajia and Zhang, Wenjing and Hao, Yazhen and Song, Jingjing and Ge, Zhaoming},
title = {Lactylation at the crossroads of metabolism and epigenetics in neuroinflammation},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1784112}
}
EUVIMED